Jonathan H Watanabe

Title(s)Clinical Professor, Clinical Pharmacy Practice
SchoolSchool of Pharmacy and Pharmaceutical Sciences
Address101 Theory, Suite 100
Irvine CA 92697-3958
Phone(949) 824-0498
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Cost Effectiveness of Letermovir for Cytomegalovirus Prophylaxis Compared with Pre-Emptive Therapy in Allogeneic Hematopoietic Stem Cell Transplant Recipients in the United States. Pharmacoecon Open. 2023 Feb 25. Sepassi A, Saunders IM, Bounthavong M, Taplitz RA, Logan C, Watanabe JH. PMID: 36840894.
      View in: PubMed   Mentions:
    2. The Critical Role of Pharmacists in Treating Older People in the Opioid Crisis. Sr Care Pharm. 2023 Feb 01; 38(2):47-49. Watanabe JH. PMID: 36751937.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    3. Senior Care Pharmacists Must Be the Disruptive Force that Reduces Adverse Drug Events in Older People. Sr Care Pharm. 2022 07 01; 37(7):247-249. Watanabe JH. PMID: 35752921.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Effects of financial toxicity on prescription drug use and mental well-being in cancer patients. Explor Res Clin Soc Pharm. 2022 Jun; 6:100136. Chan K, Sepassi A, Saunders IM, Goodman A, Watanabe JH. PMID: 35909716; PMCID: PMC9335927.
      View in: PubMed   Mentions:
    5. Examination of Medication Use Patterns by Age Group, Comorbidity, and Month in COVID-19 Positive Patients in a Large Statewide Health System During the Pandemic in 2020. J Pharm Technol. 2022 Apr; 38(2):75-87. Watanabe JH, Kwon J, Nan B, Abeles SR, Mehta SR. PMID: 35571345; PMCID: PMC9096847.
      View in: PubMed   Mentions:
    6. Risk of Negative Health Outcomes and High Costs for People With Diabetes and Unmet Psychological Needs in the United States. Diabetes Spectr. 2022; 35(2):207-215. Sepassi A, Bounthavong M, Singh RF, Heyman M, Beizai K, Watanabe JH. PMID: 35668883; PMCID: PMC9160558.
      View in: PubMed   Mentions:
    7. Transferring Key Success Factors from Ambulatory Care into the Community Pharmacy in the United States. Pharmacy (Basel). 2021 Jun 23; 9(3). Luli AJ, Awdishu L, Hirsch JD, Watanabe JH, Bounthavong M, Morello CM. PMID: 34201476; PMCID: PMC8293369.
      View in: PubMed   Mentions:
    8. Association of Age and Hospitalization Amongst Those with Underlying High-risk Conditions at COVID-19 Diagnosis in a Large, State-wide Health System. J Gen Intern Med. 2021 09; 36(9):2906-2908. Watanabe JH, Kwon J, Mehta SR. PMID: 34137004; PMCID: PMC8208375.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. When Can We Trust Real-World Data To Evaluate New Medical Treatments? Clin Pharmacol Ther. 2022 01; 111(1):24-29. Simon GE, Bindman AB, Dreyer NA, Platt R, Watanabe JH, Horberg M, Hernandez A, Califf RM. PMID: 33932030; PMCID: PMC9292968.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    10. When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments? Clin Pharmacol Ther. 2022 01; 111(1):30-34. Simon GE, Platt R, Watanabe JH, Bindman AB, John London A, Horberg M, Hernandez A, Califf RM. PMID: 33895994; PMCID: PMC8251042.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    11. When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments? Clin Pharmacol Ther. 2022 01; 111(1):108-115. Franklin JM, Platt R, Dreyer NA, London AJ, Simon GE, Watanabe JH, Horberg M, Hernandez A, Califf RM. PMID: 33826756; PMCID: PMC9291272.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    12. Medication Use Patterns in Hospitalized Patients With COVID-19 in California During the Pandemic. JAMA Netw Open. 2021 05 03; 4(5):e2110775. Watanabe JH, Kwon J, Nan B, Abeles SR, Jia S, Mehta SR. PMID: 34019090; PMCID: PMC8140369.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCellsPHPublic Health
    13. When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials? Clin Pharmacol Ther. 2022 01; 111(1):116-121. Watanabe JH, Simon GE, Horberg M, Platt R, Hernandez A, Califf RM. PMID: 33829639; PMCID: PMC9290851.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    14. DISCARDED MEDICATIONS IN VIALS ARE A SYMPTOM OF OUR HEALTH CARE SYSTEM: A CALL TO ACTION. J Manag Care Spec Pharm. 2021 May; 27(5):689-690. Watanabe JH, Lieu T, Shortliffe EH. PMID: 33908281.
      View in: PubMed   Mentions:    Fields:    Translation:PHPublic Health
    15. Associations of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use with Colorectal Cancer Risk in the Women's Health Initiative. Cancer Epidemiol Biomarkers Prev. 2021 05; 30(5):1029-1032. Brasky TM, Flores KF, Larson JC, Newton AM, Shadyab AH, Watanabe JH, Lane DS, Thomson CA, LaCroix AZ. PMID: 33627382; PMCID: PMC8102324.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    16. Comparison of botulinum toxins for treatment of movement disorders: real-world utilization and cost analysis in a national Medicare population. J Manag Care Spec Pharm. 2021 Apr; 27(4):478-487. Kazerooni R, Watanabe JH. PMID: 33511895.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Pharmacist-directed care to optimize medication use: a healthcare imperative in the United States. Expert Rev Pharmacoecon Outcomes Res. 2020 Oct; 20(5):419-421. Watanabe JH. PMID: 32902351.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    18. Association of combination opioid, benzodiazepine, and muscle relaxant usage with emergency department visits in a nationwide cohort in the United States. Int J Clin Pharm. 2021 Apr; 43(2):358-364. Watanabe JH, Yang J. PMID: 32266557.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    19. Hospitalization and Combined Use of Opioids, Benzodiazepines, and Muscle Relaxants in the United States. Hosp Pharm. 2020 Oct; 55(5):286-291. Watanabe JH, Yang J. PMID: 32999498; PMCID: PMC7502868.
      View in: PubMed   Mentions: 6  
    20. Advancing Pharmacist Collaborative Care within Academic Health Systems. Pharmacy (Basel). 2019 Oct 11; 7(4). Awdishu L, Singh RF, Saunders I, Yam FK, Hirsch JD, Lorentz S, Atayee RS, Ma JD, Tsunoda SM, Namba J, Mnatzaganian CL, Painter NA, Watanabe JH, Lee KC, Daniels CD, Morello CM. PMID: 31614555; PMCID: PMC6958419.
      View in: PubMed   Mentions: 9  
    21. Examining the Pharmacist Labor Supply in the United States: Increasing Medication Use, Aging Society, and Evolution of Pharmacy Practice. Pharmacy (Basel). 2019 Sep 19; 7(3). Watanabe JH. PMID: 31546891; PMCID: PMC6789639.
      View in: PubMed   Mentions: 2  
    22. Anticoagulant Use in High Stroke-Risk Patients With Nonvalvular Atrial Fibrillation. Consult Pharm. 2018 Sep 01; 33(9):521-530. Nguyen HK, Humber D, Checkoway H, Blanchard D, Watanabe JH. PMID: 30185292.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    23. Federal and Individual Spending on the 10 Costliest Medications in Medicare Part D from 2011 to 2015. J Am Geriatr Soc. 2018 08; 66(8):1621-1624. Watanabe JH, Chau DL, Hirsch JD. PMID: 29972589.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    24. Medication Regimen Complexity in Long-Term Care Facilities and Adverse Drug Events-Related Hospitalizations. Consult Pharm. 2017 May 01; 32(5):281-284. Tam SHY, Hirsch JD, Watanabe JH. PMID: 28483008.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    25. Medication Use, Falls, and Fall-Related Worry in Older Adults in the United States. Consult Pharm. 2016 Jul; 31(7):385-93. Watanabe JH. PMID: 27412315.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    26. An evaluation of health care expenditures in Crohn's disease using the United States Medical Expenditure Panel Survey from 2003 to 2013. Res Social Adm Pharm. 2017 May - Jun; 13(3):530-538. Bounthavong M, Li M, Watanabe JH. PMID: 27263802.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    27. Value of Information in Asia: Concepts, Current Use, and Future Directions. Value Health Reg Issues. 2016 May; 9:99-104. Dilokthornsakul P, McQueen RB, Chaiyakunapruk N, Spackman E, Watanabe JH, Campbell JD. PMID: 27881269.
      View in: PubMed   Mentions:    Fields:    
    28. Association of increased emergency rooms costs for patients without access to necessary medications. Res Social Adm Pharm. 2015 Jul-Aug; 11(4):499-506. Watanabe JH, Ney JP. PMID: 25487421.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Association of copayment with likelihood and level of adherence in new users of statins: a retrospective cohort study. J Manag Care Pharm. 2014 Jan; 20(1):43-50. Watanabe JH, Kazerooni R, Bounthavong M. PMID: 24372459.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    30. Association between statin adherence and cholesterol level reduction from baseline in a veteran population. Pharmacotherapy. 2013 Oct; 33(10):1044-52. Kazerooni R, Watanabe JH, Bounthavong M. PMID: 23744794.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    With one click, see people who:

    Run Clinical Trials

    See more options in the Advanced Search tab

    Jonathan's Networks
    Concepts (120)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (24)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCI Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).
    This site is running Profiles RNS version pre_new_search-4-g7119b7be on PROFILES-PWEB03.

    Copyright © The Regents of the University of California